Pre-made Isatuximab biosimilar ( Whole mAb, anti-CD38 therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-279
Anti-CD38 therapeutic antibody (Pre-made Isatuximab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Isatuximab, sold under the brand name Sarclisa, is a monoclonal antibody (mAb) medication for the treatment of multiple myeloma.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-CD38 therapeutic antibody (Pre-made Isatuximab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||4cmh:BC|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||ImmunoGen;Huntsman Cancer Institute;Roche;Sanofi|
|Conditions Approved||Multiple myeloma|
|Conditions Active||Acute myeloid leukaemia;Precursor cell lymphoblastic leukaemia-lymphoma;Colorectal cancer;Diffuse large B cell lymphoma;Hodgkin's disease;Solid tumours;Urogenital cancer|
|Conditions Discontinued||Non-small cell lung cancer;Prostrate cancer;T-cell lymphoma|